World's Best Scientists 2026 revealed!
Antonio Craxì

Antonio Craxì

Award Badge
Medicine
Italy
2023

D-Index & Metrics

Medicine

D-Index
111
Citations
63321
World Ranking
5244
National Ranking
168

Research.com Recognitions

  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Antonio Craxì is affiliated with the University of Palermo in Italy. Their research primarily focuses on medicine, with an emphasis on epidemiology, hepatology, infectious diseases, oncology, and surgery. The main topics covered in their scholarly work include liver disease diagnosis and treatment, hepatitis C virus research, hepatitis B virus studies, liver disease and transplantation, liver diseases and immunity, hepatocellular carcinoma treatment and prognosis, and endoplasmic reticulum stress and disease.

Antonio Craxì's publications have appeared frequently in several prominent journals, including:

  • Digestive and Liver Disease
  • Journal of Hepatology
  • Liver International
  • Nutrition Metabolism and Cardiovascular Diseases
  • SSRN Electronic Journal

Among recent publications, some notable works are:

  • "Advancing the global public health agenda for NAFLD: a consensus statement" (2021) in Nature Reviews Gastroenterology & Hepatology
  • "Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study" (2022) in The Lancet. Gastroenterology & hepatology
  • "Impact of COVID-19 on global HCV elimination efforts" (2020) in Journal of Hepatology
  • "Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease" (2020) in Clinical Gastroenterology and Hepatology
  • "Hepatitis B Virus-Associated Hepatocellular Carcinoma" (2022) in Viruses

Collaboration is a significant part of Antonio Craxì's research, with frequent co-authors including Salvatore Petta, V. Di Marco, Calogero Cammà, Grazia Pennisi, and Vincenza Calvaruso. These collaborations number in the dozens and reflect a strong network within their research community.

Best Publications

  • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

    Michael W. Fried;Mitchell L. Shiffman;K. Rajender Reddy;Coleman Smith

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

    Chris Estes;Quentin M. Anstee;Maria Teresa Arias-Loste;Heike Bantel

  • EASL Clinical Practice Guidelines: Management of hepatitis C virus infection European Association for the Study of the Liver ⇑

    Markus Peck;Antonio Craxi;Michael Fried;Stefan Zeuzem

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

    Gary L. Davis;Rafael Esteban-Mur;Vinod Rustgi;John Hoefs

  • Statements from the Taormina expert meeting on occult hepatitis B virus infection.

    Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.

    Calogero Cammà;Marco Giunta;Francesco Fiorica;Luigi Pagliaro

  • Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

    Calogero Cammà;Filippo Schepis;Ambrogio Orlando;Maddalena Albanese

  • Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

    Jordi Bruix;Jean Luc Raoul;Morris Sherman;Vincenzo Mazzaferro

  • Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

    F. Fiorica;D. D. Bona;Filippo Schepis;A. Licata

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

    Peter Ferenci;Michael W. Fried;Mitchell L. Shiffman;Coleman I. Smith

  • A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis

    Scott L. Friedman;Vlad Ratziu;Stephen A. Harrison;Manal F. Abdelmalek

  • The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

    Rosellina Margherita Mancina;Paola Dongiovanni;Salvatore Petta;Piero Pingitore

  • Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C

    Salvatore Petta;Calogero Cammà;Concetta Scazzone;Claudio Tripodo

  • Hepatitis B virus maintains its pro-oncogenic properties in the case of Occult HBV infection

    Teresa Pollicino;Giovanni Squadrito;Giovanni Cerenzia;Irene Cacciola

  • Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

    Paola Dongiovanni;Salvatore Petta;Cristina Maglio;Anna Ludovica Fracanzani

  • A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.

    Giuseppe Cabibbo;Marco Enea;Massimo Attanasio;Jordi Bruix

Frequent Co-Authors

Salvatore Petta
Salvatore Petta University of Palermo
Calogero Cammà
Calogero Cammà University of Palermo
Silvia Fargion
Silvia Fargion University of Milan
Luca Valenti
Luca Valenti University of Milan
Alfredo Alberti
Alfredo Alberti University of Padua
Massimo Colombo
Massimo Colombo Humanitas University
Elisabetta Bugianesi
Elisabetta Bugianesi University of Turin
Antonio Gasbarrini
Antonio Gasbarrini Catholic University of the Sacred Heart
Massimo Puoti
Massimo Puoti University of Milano-Bicocca
Francesca Ceccherini-Silberstein
Francesca Ceccherini-Silberstein University of Rome Tor Vergata

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to many related careers and advanced degrees. Online programs now make these pathways more accessible, allowing students to balance studies, work, and personal commitments.

For those interested in healthcare leadership, pursuing an online master of health administration offers preparation for roles in hospital management or public health organizations. Choosing a degree from one of the cheapest mha programs can make this advanced education more affordable without sacrificing quality.

Nurses seeking to reach the highest levels of practice may consider enrolling in one of the least expensive dnp programs. This route is ideal for those aiming for leadership, clinical, or academic roles in nursing.

For pharmacy professionals, an accelerated 3 year online pharmd program provides a flexible and cost-effective way to advance expertise and open up new career options.

Choosing the right online program can help you reach your career goals in healthcare, while offering the flexibility and affordability today’s students need.

Best Scientists Citing Antonio Craxì

Trending Scientists